AIDS Drug Assistance Program

This blog focuses on the federal commitment to fully fund the AIDS Drug Assistance Program (ADAP) for people living with HIV/AIDS.

Thursday, May 27, 2021

Co-Infection: HIV & Hepatitis C Therapies Under State AIDS Drug Assistance Programs

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association According to amfAR, The Foundation for AIDS Research, there are an estimated 1.2 mill...
Thursday, May 20, 2021

Danger Zone: Intimate Partner Violence Among People Living with HIV

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association The U.S. Centers for Disease Control & Prevention (CDC) recently reported what to...
Thursday, May 13, 2021

PLWHA Perspectives on Covid-19

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association The ADAP Advocacy Association has dedicated significant resources over the last year ...
Thursday, May 6, 2021

Co-Pay Accumulators are an Extremely Dangerous, Anti-Patient Policy

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association Today's lexicon outside healthcare policy discussions probably doesn't includ...
Thursday, April 29, 2021

Still Protected! Medicare's Six Protected Drug Classes Policy Survives Trump's Attack

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association In the waning days of the Trump Administration, Medicare Part D once again faced a se...
Thursday, April 22, 2021

New CDC Surveillance Reveals Risks Among Transgender Women, Including HIV

›
By: Jen Laws, Board Member, ADAP Advocacy Association, and HIV/transgender health advocate   On April 15, 2021, the U.S. Centers for Disease...
Thursday, April 15, 2021

It Is Time to Advocate for the Patient

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association        Jeffrey R. Lewis, President & CEO, Legacy Health Endowment         (The vi...
‹
›
Home
View web version

About Me

My photo
ADAP Advocacy
View my complete profile
Powered by Blogger.